Oncotarget CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more October 7, 2022
Oncotarget Trending With Impact: Genes Identified in Endocrine Therapy Resistance Researchers studied the dynamic behavior of gene expression during the development of endocrine therapy resistance... read more April 14, 2022
Oncotarget A Remote Weight Loss Strategy for Breast Cancer Survivors Researchers Jennifer Y. Sheng and Vered Stearns discussed the results of a study that compared... read more March 9, 2022
Oncotarget Trending With Impact: Are NOTCH1 Variants Prognostic in Breast Cancer? Researchers determined the prognostic ability of three NOTCH1 gene variants by incorporating them into two... read more February 24, 2022
Oncotarget Chemical in Sunscreen Promotes Breast Cancer in Diet-Dependent Manner The bioactivity of oxybenzone—a harmful chemical often found in sunscreens—was examined within mouse... read more November 17, 2021
Oncotarget New Study: Vaccine Enhances Breast Cancer Treatment Researchers conducted a study to examine the efficacy of adding the P10s-PADRE vaccine to chemotherapy... read more October 27, 2021
Oncotarget Behind the Study: EMT, Endothelial Cells & Tumor Growth Dr. Tapasree Roy Sarkar from the Department of Biology at Texas A&M University... read more September 13, 2021
Oncotarget New Study: How Exercise Boosted Chemotherapy in Mice A new study demonstrates how exercise impacts a highly-prescribed chemotherapeutic agent, doxorubicin, in murine models... read more September 1, 2021
Oncotarget Trending With Impact: Analysis of Breast Cancer in Nigerian Women In this trending paper published by Oncotarget in 2021, a cohort of Nigerian women were... read more August 12, 2021
Oncotarget Biomarker Predicts Treatment Efficacy in Triple-Negative Breast Cancer In this 2020 paper, researchers searched for biomarkers of sacituzumab govitecan treatment efficacy in triple-negative... read more July 27, 2021